Literature DB >> 15563594

A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.

Rui-Hong Wang1, Hongtao Yu, Chu-Xia Deng.   

Abstract

BRCA1-associated breast cancer exhibits significantly higher levels of chromosomal abnormalities than sporadic breast cancers. However, the molecular mechanisms regarding the roles of BRCA1 in maintaining genome integrity remain elusive. By using a mouse model deficient for Brca1 full-length isoform (Brca1(Delta11/Delta11)), we found that Brca1(Delta11/Delta11) cells displayed decreased expression of a number of genes that are involved in the spindle checkpoint, including Mad2, which is a key component of spindle checkpoint that inhibits anaphase-promoting complex. We showed that Brca1(Delta11/Delta11) cells failed to arrest at metaphase in the presence of nocodazole and underwent apoptosis because of activation of p53. Consistently, reconstitution of Mad2 in Brca1(Delta11/Delta11) cells partially restored the spindle checkpoint and attenuated apoptosis. By using UBR60 cells, which carry tetracycline-regulated expression of BRCA1, we demonstrated that BRCA1 binds to transcription factor OCT-1 and up-regulates the transcription of MAD2. Furthermore, we showed that the induction of BRCA1 to endogenous MAD2 or transfected MAD2 luciferase reporter in UBR60 cells was completely inhibited by acute suppression of BRCA1 by RNA interference. These data reveal a role of BRCA1 in maintaining genome integrity by interplaying with p53 and genes that are involved in the spindle checkpoint and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563594      PMCID: PMC535394          DOI: 10.1073/pnas.0407585101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Roles of BRCA1 and its interacting proteins.

Authors:  C X Deng; S G Brodie
Journal:  Bioessays       Date:  2000-08       Impact factor: 4.345

2.  Mad2-Independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1.

Authors:  Z Tang; R Bharadwaj; B Li; H Yu
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

Review 3.  Waiting for anaphase: Mad2 and the spindle assembly checkpoint.

Authors:  J V Shah; D W Cleveland
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

4.  Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

Authors:  X Xu; W Qiao; S P Linke; L Cao; W M Li; P A Furth; C C Harris; C X Deng
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

Review 5.  Lessons learned from BRCA1 and BRCA2.

Authors:  L Zheng; S Li; T G Boyer; W H Lee
Journal:  Oncogene       Date:  2000-12-11       Impact factor: 9.867

6.  MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells.

Authors:  L S Michel; V Liberal; A Chatterjee; R Kirchwegger; B Pasche; W Gerald; M Dobles; P K Sorger; V V Murty; R Benezra
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

7.  Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice.

Authors:  C X Deng
Journal:  Mutat Res       Date:  2001-06-02       Impact factor: 2.433

8.  Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Authors:  Y Shang; X Hu; J DiRenzo; M A Lazar; M Brown
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

9.  Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2.

Authors:  M Dobles; V Liberal; M L Scott; R Benezra; P K Sorger
Journal:  Cell       Date:  2000-06-09       Impact factor: 41.582

10.  Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2.

Authors:  V Sudakin; G K Chan; T J Yen
Journal:  J Cell Biol       Date:  2001-09-03       Impact factor: 10.539

View more
  65 in total

1.  Genomic instability in chronic myeloid leukemia: targets for therapy?

Authors:  N Muvarak; P Nagaria; F V Rassool
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

Review 2.  The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks.

Authors:  Karina Vázquez-Arreguín; Dean Tantin
Journal:  Biochim Biophys Acta       Date:  2016-02-10

3.  Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform.

Authors:  Sang Soo Kim; Liu Cao; Sung-Chul Lim; Cuiling Li; Rui-Hong Wang; Xiaoling Xu; Richard Bachelier; Chu-Xia Deng
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

4.  A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress.

Authors:  Jinsuk Kang; Matthew Gemberling; Mitsuhiro Nakamura; Frank G Whitby; Hiroshi Handa; William G Fairbrother; Dean Tantin
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

5.  Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53.

Authors:  T Fishler; Y-Y Li; R-H Wang; H-S Kim; K Sengupta; A Vassilopoulos; T Lahusen; X Xu; M-H Lee; Q Liu; S-J Elledge; T Ried; C-X Deng
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

6.  The spindle assembly checkpoint: More than just keeping track of the spindle.

Authors:  Katherine S Lawrence; JoAnne Engebrecht
Journal:  Trends Cell Mol Biol       Date:  2015

7.  Regulation of Oct1/Pou2f1 transcription activity by O-GlcNAcylation.

Authors:  Jinsuk Kang; Zuolian Shen; Jae-Min Lim; Hiroshi Handa; Lance Wells; Dean Tantin
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

8.  Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis.

Authors:  Rui-Hong Wang; Yin Zheng; Hyun-Seok Kim; Xiaoling Xu; Liu Cao; Tyler Luhasen; Mi-Hye Lee; Cuiying Xiao; Athanassios Vassilopoulos; Weiping Chen; Kevin Gardner; Yan-Gao Man; Mien-Chie Hung; Toren Finkel; Chu-Xia Deng
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

Review 9.  Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy?

Authors:  J Thomas De Ligio; Aneliya Velkova; Diego A R Zorio; Alvaro N A Monteiro
Journal:  Anticancer Agents Med Chem       Date:  2009-06       Impact factor: 2.505

10.  Age-associated increase in aneuploidy and changes in gene expression in mouse eggs.

Authors:  Hua Pan; Pengpeng Ma; Wenting Zhu; Richard M Schultz
Journal:  Dev Biol       Date:  2008-02-15       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.